Abstract
This article describes the first two years of Norplant implants use among 1560 acceptors in four counties of rural north China. Continuation of use was high, 88.4% after two years. Disruption of the menstrual cycle was the predominant side effect and the predominant reason for termination. Clinical performance among the four counties was diverse, with two-year continuation rates ranging from 73.9% to 95.3%. Factors that may contribute to the diversity among study sites and the overall high continuation rate are discussed in the context of Chinese family planning.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.